Emerson Perin, medical director of The Texas Heart Institute, is focused on curing heart failure. With the power of innovation and a strong team, the Houston-based cardiologist has a good chance of meeting his objective.| InnovationMap
For 60 years, the Texas Heart Institute has been a part of Houston's innovation DNA. The organization's founder, Dr. Denton Cooley, performed first total artificial heart implantation in 1969 at THI. Now, decades later, the institutions third CEO continues to lead the innovation within cardiovascular care.| InnovationMap
Heart disease is one of the most common causes of death in the United States — one in five deaths, according to the CDC. But there's not a long-term solutions for patients — even for those lucky enough to have a successful heart transplant.| InnovationMap
The Texas Heart Institute lab creates ghost hearts — organs from which all cells are scrubbed, leaving collagen, fibronectin, and laminin in the shape of the formerly beating ticker. The goal is to use the decellularized organs as protein scaffolds that will once again contract and pump blood.| InnovationMap
A Houston company with a breakthrough heart health tech has received a green light from the FDA.| InnovationMap
Houston-based medtech company BiVACOR has picked up $22 million in funding — in the form of a series B round and a federal grant — to propel development of its Total Artificial Heart device for treatment of severe heart failure.| InnovationMap
Meet Yaxin Wang, PhD. The research engineer leads the IDEA Lab at THI. IDEA stands for Innovative Device & Engineering Applications, an apt description of what Wang and her colleagues do.| InnovationMap
